ArticleFrontiers in oncology2026
Construction and validation of a risk prediction model for perianal infection in HSCT patients: a retrospective cohort study.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perianal infection is a frequent and detrimental complication in patients undergoing hematopoietic stem cell transplantation (HSCT), leading to significant morbidity and extended hospital stays. Despite its clinical significance, a substantial gap remains in our ability to proactively identify high-risk individuals. However a validated predictive model is actually lacking and it is still unclear how to identify these patients before the onset of infection. Objective: This study aimed to develop and to validate a risk prediction model for the accurate assessment of perianal infection risk following HSCT. Methods: A total of 353 patients who underwent HSCT between January 2020 and June 2023 were retrospectively enrolled in this study. The dataset was randomly split into a training cohort (n = 247) and a validation cohort (n = 106) at a ratio of 7:3. Univariate and multivariate logistic regression analyses were employed to identify independent risk factors. Based on these factors, a nomogram prediction model was constructed. Restricted cubic splines were used to assess nonlinear relationships. Model validation included discrimination (AUC), calibration (Hosmer-Lemeshow test), and clinical utility (decision curve analysis). Results: The independent risk factors of perianal infection following HSCT are the type of HSCT, history of perianal disease, diarrhea, neutropenia length, and preoperative prognostic nutritional index. In the training group, the model achieved an AUC of 0.846 (95% CI: 0.775-0.918), an accuracy of 81.0%, a sensitivity of 77.1%, a specificity of 81.9%, and a Youden's index of 0.590. Subsequently, the validation group was assessed, showing an AUC of 0.829 (95% CI: 0.696-0.963), an accuracy of 73.6%, a sensitivity of 87.5%, a specificity of 71.1%, and a Youden's index of 1.586. Model validation showed good calibration agreement. Decision curve analysis demonstrated clinically meaningful net benefit across a wide range of probability thresholds. Restricted cubic spline analysis revealed nonlinear associations of neutropenia length and preoperative PNI with perianal infection risk, with threshold analysis identifying clinically relevant inflection points. Conclusion: This study has constructed a simple, feasible, and visual nomogram for evaluating and early warning of perianal infection following HSCT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.